Scilex Pharmaceuticals Inc.

MALVERN, PA · Founded 2012 · CIK 0001603542 · Medtech

Transdermal patch technology for optimized percutaneous drug delivery

scilexholding.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$7.5M
4 Form D · May 2016
125 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,001,700
Private capital raisedForm D · SEC$5,001,700
Private capital raisedForm D · SEC$2,025,274
Private capital raisedForm D · SEC$479,930
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1913Sanguine Diagnostics And Therapeutics, Inc.——
1914GUANINE, INC.——
1915Advanced Biosensors Inc.——
1916Scilex Pharmaceuticals Inc.—$7.5M
1917Stratagen Bio, Inc.——
1918Osheru, Inc.—$5.0M
1919REVEAL BIOSCIENCES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Richard CohenExecutive Officer
  • Eric FloydDirector
  • Anthony MackDirector · Executive Officer
  • William PedrantiDirector · Executive Officer
  • Jerrold SendrowDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.